Gold-Nanoparticle-Based Multifunctional Amyloid-β Inhibitor against Alzheimer's Disease

被引:141
作者
Gao, Nan [1 ]
Sun, Hanjun [1 ]
Dong, Kai [1 ]
Ren, Jinsong [1 ]
Qu, Xiaogang [1 ]
机构
[1] Chinese Acad Sci, Changchun Inst Appl Chem, State Key Lab Rare Earth Resource Utilizat, Lab Chem Biol,Div Biol Inorgan Chem,Univ Chinese, Changchun 130022, Jilin, Peoples R China
关键词
drug design; peptides; gold; nanoparticles; polyoxometalates; DAWSON-TYPE POLYOXOTUNGSTATES; PROTEIN FIBRILLATION; WELLS-DAWSON; PEPTIDE; BINDING; AGENTS; COPPER; WATER;
D O I
10.1002/chem.201404562
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Targeting amyloid-beta (A beta)-induced complex neurotoxicity has received considerable attention in the therapeutic and preventive treatment of Alzheimer's disease (AD). The complex pathogenesis of AD suggests that it requires comprehensive treatment, and drugs with multiple functions against AD are more desirable. Herein, AuNPs@POMD-pep (AuNPs: gold nanoparticles, POMD: polyoxometalate with Wells-Dawson structure, pep: peptide) were designed as a novel multifunctional A beta inhibitor. AuNPs@POMD-pep shows synergistic effects in inhibiting A beta aggregation, dissociating A beta fibrils and decreasing A beta-mediated peroxidase activity and A beta-induced cytotoxicity. By taking advantage of AuNPs as vehicles that can cross the blood-brain barrier (BBB), AuNPs@POMD-pep can cross the BBB and thus overcome the drawbacks of small-molecule anti-AD drugs. Thus, this work provides new insights into the design and synthesis of inorganic nanoparticles as multifunctional therapeutic agents for treatment of AD.
引用
收藏
页码:829 / 835
页数:7
相关论文
共 46 条
[1]  
[Anonymous], 2002, ANGEW CHEM
[2]   Highly efficient peptide bond formation to functionalized Wells-Dawson-type polyoxotungstates [J].
Bareyt, S ;
Piligkos, S ;
Hasenknopf, B ;
Gouzerh, P ;
Lacôte, E ;
Thorimbert, S ;
Malacria, M .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (29) :3404-3406
[3]   Efficient preparation of functionalized hybrid organic/inorganic Wells- Dawson-type polyoxotungstates [J].
Bareyt, S ;
Piligkos, S ;
Hasenknopf, B ;
Gouzerh, P ;
Lacôte, E ;
Thorimbert, S ;
Malacria, M .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2005, 127 (18) :6788-6794
[4]  
Bareyt S., 2003, ANGEW CHEM, V115, P3526
[5]   Platinum-based inhibitors of amyloid-β as therapeutic agents for Alzheimer's disease [J].
Barnham, Kevin J. ;
Kenche, Vijaya B. ;
Ciccotosto, Giuseppe D. ;
Smith, David P. ;
Tew, Deborah J. ;
Liu, Xiang ;
Perez, Keyla ;
Cranston, Greg A. ;
Johanssen, Timothy J. ;
Volitakis, Irene ;
Bush, Ashley I. ;
Masters, Colin L. ;
White, Anthony R. ;
Smith, Jeffrey P. ;
Cherny, Robert A. ;
Cappai, Roberto .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (19) :6813-6818
[6]   Regioselective activation of oxo ligands in functionalized Dawson polyoxotungstates [J].
Boglio, Cecile ;
Micoine, Kevin ;
Derat, Etienne ;
Thouvenot, Rene ;
Hasenknopf, Bernold ;
Thorimbert, Serge ;
Lacote, Emmanuel ;
Malacria, Max .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (13) :4553-4561
[7]   Inhibition of Amyloid β Protein Fibrillation by Polymeric Nanoparticles [J].
Cabaleiro-Lago, Celia ;
Quinlan-Pluck, Fiona ;
Lynch, Iseult ;
Lindman, Stina ;
Minogue, Aedin M. ;
Thulin, Eva ;
Walsh, Dominic M. ;
Dawson, Kenneth A. ;
Linse, Sara .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2008, 130 (46) :15437-15443
[8]   Mono-substituted Keggin, Wells-Dawson and {P2W21}-type polyoxometalates without positional disorder [J].
Cao, Rui ;
O'Halloran, Kevin P. ;
Hillesheim, Daniel A. ;
Hardcastle, Kenneth I. ;
Hill, Craig L. .
CRYSTENGCOMM, 2010, 12 (05) :1518-1525
[9]   Transition-metal-substituted polyoxometalate derivatives as functional anti-amyloid agents for Alzheimer's disease [J].
Gao, Nan ;
Sun, Hanjun ;
Dong, Kai ;
Ren, Jinsong ;
Duan, Taicheng ;
Xu, Can ;
Qu, Xiaogang .
NATURE COMMUNICATIONS, 2014, 5
[10]  
Geng J., 2011, ANGEW CHEM, V123, P4270, DOI DOI 10.1002/ANGE.201007067